Through the European Asthma Research and Innovation Partnership (EARIP), we have developed a roadmap for future investment in asthma research and care. Priorities for research were initially identified by conducting an analysis of asthma overview documents from leading international and European medical societies, patient organisations and policy makers in the field of asthma. To ensure the priorities were relevant for those living with asthma and carers of people with asthma, nearly 1,600 patients across Europe helped to identify priorities for them through a Europe-wide questionnaire. Following this initial prioritisation, workshop with 31 individuals (those living with asthma, patient organisation representatives, industry representatives and world-leading asthma clinicians and researchers) worked to establish 15 key priorities.
The 15 priorities of the asthma research roadmap fall into 2 main areas of unmet need which are Biomarkers - unravelling the ‘types’ of asthma and optimising treatments and technology-enabled asthma self-management - improving patient adherence and expanding our research. These areas need more research investment to stop asthma attacks and help cure asthma.
To make these priorities usable for researchers and researcher funders, specific research questions were developed for the 15 priorities. These were developed by experts in each field to add further specificity and direction to the priorities, making it easier for the priorities to be taken up in the research work plans of the European Commission, research institutes and industry.
There is no doubt that a unified approach to innovation is needed to address the challenge of asthma. It is the opinion of the EARIP project and workshop participants that if all of these research priority areas were funded and research questions addressed asthma outcomes would be transformed.